All participants will be receiving the study drug

Tracheostomy Infection

Inhaled antibiotic with anti-pseudomonal properties

Inhaled Aztreonam

Benioff Children's Hospital Oakland

The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas

A-PACT: The Use of Inhaled Aztreonam to Eliminate or Decrease the Bacterial Burden of Pseudomonas Aeruginosa in Children With a Tracheostomy Tube.

See if the number of days of systemic antibiotics needed decreases after participant starts using the study drug. (compare 1 year prior to starting study drug to the 1 year while patient is on the study drug)

See if bacterial density of Pseudomonas is decreased or eliminated with the study drug (will compare all cultures from the year prior to starting the trial to the year during the trial)

to see if there is a difference in how effective the study drug is depending on what type of trach tube the subject has. Will assess this by looking at the Pseudomonas bacterial density from the tracheostomy tube cultures from the year prior to starting the study drug and compare to the year while on the study drug.

Can study drug decrease number of hospital admissions form the year prior to starting the study drug compared to the year while taking the study drug

Can the study drug decrease the duration of hospitalizations from the year prior to starting the study drug compared to the year while taking the study drug

antipseudomonal/galvos skausmas

The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu